Skip to main content
. 2022 Sep 5;13:944886. doi: 10.3389/fphar.2022.944886

FIGURE 1.

FIGURE 1

Body weight, fat mass and biochemical parameters in HFD mice with or without empagliflozin. (A) Morphology of mice. (B) Weekly body weights. (C) Body fat mass of the mice. (D) Body fat/body weight. (E) Plasma triglycerides levels. (F) Plasma free fatty acid levels. (G) Lipid peroxidation MDA levels. (H) Fasting glucose levels. (I) Urine glucose. Data are presented as means ± SEM (n = 4-6/group); *p < 0.05.